Medite Cancer Diagnostics, Inc.
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|---|
| Revenue | $6.8M | $9.2M | $9.9M | $11.0M | $10.0M | $198,000 |
| Operating income | −$6.5M | −$1.7M | −$599,000 | −$394,000 | $294,000 | −$1.3M |
| Net income | −$6.8M | −$2.2M | −$859,000 | −$699,000 | $54,000 | −$1.5M |
| Total assets | $16.0M | $17.6M | $18.4M | $18.6M | $8.2M | $262,000 |
| Total liabilities | $10.2M | $9.5M | $9.2M | $10.2M | $5.5M | — |
| Equity | $5.8M | $8.0M | $9.2M | $8.4M | $2.6M | $2.4M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 22.4M | 21.1M | 19.7M | 1.90B | 74.7M | 68.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- −95.1%
- Net margin
- −100.0%
- Return on equity
- −117.9%
- Return on assets
- −42.7%
- Return on capital (ROCE)
- −53.2%
- Liabilities / assets
- 63.8%
- Debt / equity
- 1.76×
- Book value / share
- $0.26
- Revenue growth (YoY)
- −26.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Altman Z″ (distress)
- -3.94distress
- Accruals / assets
- −20.3%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2019
- NT 10-Qmissed a reporting deadline ↗May 14, 2018
- NT 10-Kmissed a reporting deadline ↗Mar 29, 2018
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2017
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2016
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2016
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Director / officer changeMay 6, 2019
- Other material eventApr 23, 2019
- Director / officer changeMar 18, 2019
- Bankruptcy or receivershipJan 3, 2019
- Entered a material agreement · Director / officer changeDec 6, 2018
- Director / officer changeOct 31, 2018
- Entered a material agreement · New financial obligation · Unregistered equity saleOct 16, 2018
- Entered a material agreement · Director / officer changeOct 1, 2018
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KCURRENT REPORTMay 6, 2019
- 8-KCURRENT REPORTApr 23, 2019
- 15-12G/AApr 2, 2019
- NT 10-KApr 1, 2019
- 15-12GFORM 15Mar 22, 2019
- 8-KCURRENT REPORTMar 18, 2019
- PRE 14CFeb 28, 2019
- 8-KCURRENT REPORTJan 3, 2019
- 8-KCURRENT REPORTDec 6, 2018
- 10-QQUARTERLY REPORTNov 14, 2018
- 8-K/ANov 7, 2018
- SC 13G/AAMENDMENT NO. 1 TO THE SCHEDULE 13GNov 2, 2018
- 8-KCURRENT REPORTOct 31, 2018
- DOct 26, 2018
- 4Oct 23, 2018
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.